Attached files
| file | filename |
|---|---|
| EX-31.2 - Brooklyn ImmunoTherapeutics, Inc. | ex31-2.htm |
| 10-K/A - Brooklyn ImmunoTherapeutics, Inc. | form10-ka.htm |
EXHIBIT 31.1
CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO
SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a), AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Allen Wolff, certify that:
1. I have reviewed this Amendment No. 1 on Form 10-K/A to the Annual Report on Form 10-K of NTN Buzztime, Inc.; and
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
| Dated: April 27, 2020 | /s/ Allen wolff | |
Allen Wolff, Chief Executive Officer NTN Buzztime, Inc. |